Kenney Blasts Trudeau’s Expansion of Temporary Foreign Worker Program
Former Alberta Premier Jason Kenney has launched a scathing critique of the federal government’s immigration policies, particularly targeting its approach to foreign labor. Kenney, who previously served as the Conservative immigration minister under Stephen Harper, said on X that he’s “perplexed” at what he described as the gross mismanagement of the immigration system by Prime […]
Bangladesh Regulatory Body Embarks To Take Down Market Manipulation
The Bangladesh Securities and Exchange Commission (BSEC) is embarking on a sweeping crackdown on market manipulation and corruption, signaling a renewed commitment to restoring trust and transparency in the country’s financial markets. Khondoker Rashed Maqsood, the newly appointed chairman of the BSEC, announced the commission’s aggressive stance at a recent press conference, marking a decisive […]
Electra Secures Game-Changing Department of Defense Contract
In this interview, Trent Mell, CEO of Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM), shares the details behind the company’s recent $20 million funding from the US Department of Defense. This investment, aimed at supporting the construction of a cobalt refinery in Canada, is part of a broader strategy to reduce dependence on China […]
Home Depot Ends Marijuana Testing for Most Employees
Home Depot Inc (NYSE: HD), one of America’s largest employers, plans to remove marijuana from its drug screening panels and discontinue pre-employment drug testing for the majority of its workforce. The changes, set to take effect on September 1, 2024, were outlined in a human resources memo obtained by Marijuana Moment. According to the document, […]
Crypto Mining Firm Rhodium Enters Bankruptcy, Revealing $100M in Liabilities
Bitcoin mining firm Rhodium Enterprises has filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the Southern District of Texas. The filing, submitted on August 24, 2024, includes six subsidiaries and reveals liabilities between $50 million and $100 million, with assets estimated between $100 million and $500 million. This development follows […]
National Bank’s Shares Soar on Robust Q3 2024 Earnings
National Bank of Canada (TSX: NA) has seen a 5% surge in its share price on the TSX following the release of its third-quarter earnings report for 2024. The bank reported a net income of $1.03 billion for the quarter ended July 31, 2024, marking a 24% increase from $830 million in the same period […]
RBC Smashes Q3 2024 Earnings Expectations with HSBC Boost
The Royal Bank of Canada (TSX: RY) delivered a robust financial performance in the third quarter of its fiscal year 2024, surpassing analysts’ expectations. This quarter marked RBC’s first full reporting period since the completion of its $13.5 billion acquisition of HSBC’s Canadian operations, a strategic move that significantly bolstered the bank’s financials. RBC reported […]
Government Fast-Tracked Temporary Foreign Worker Applications By Skipping Fraud Checks, Report Reveals
An investigation by the Toronto Star has revealed that the Canadian government is expediting applications for the Temporary Foreign Worker program by “directing processing officers to skip crucial steps designed to prevent fraud.” This comes as Prime Minister Justin Trudeau recently announced measures to tighten the program, which the government admits has been abused. According […]
Red Pine Exploration Reports Mineral Resources Of 1.68 Million Gold Ounces
Red Pine Exploration (TSXV: RPX) is reporting a substantial improvement in mineral resources at its flagship Wawa Gold project in Ontario. The new estimate follows the company being forced to conduct an independent review of its assay results following the discovery that assay results had been tampered with. The new mineral resource estimate is said […]
PharmaDrug Subsidiary To Focus Development Of PD-001 On Viral Infectious Diseases
PharmaDrug (CSE: PHRX) this morning revealed the strategic plans for its Sairiyo Therapeutics subsidiary in relation to the clinical development of PD-001, its patented formulation for an enteric-coated version of cepharanthine.